|
Atomistry » Fluorine » PDB 4q0e-4qrc » 4qpf | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 4q0e-4qrc » 4qpf » |
Fluorine in PDB 4qpf: New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone ResorptionEnzymatic activity of New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption
All present enzymatic activity of New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption:
2.5.1.1; 2.5.1.10; Protein crystallography data
The structure of New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption, PDB code: 4qpf
was solved by
F.H.Ebetino,
M.Lundy,
A.A.Kwaasi,
J.E.Dunford,
Z.Duan,
J.Triffitt,
A.Mazur,
G.Jeans,
B.L.Barnett,
R.G.G.Russell,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 4qpf:
The structure of New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption
(pdb code 4qpf). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption, PDB code: 4qpf: Fluorine binding site 1 out of 1 in 4qpfGo back to Fluorine Binding Sites List in 4qpf
Fluorine binding site 1 out
of 1 in the New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption
Mono view Stereo pair view
Reference:
F.H.Ebetino,
M.Lundy,
A.A.Kwaasi,
J.E.Dunford,
Z.Duan,
J.Triffitt,
A.Mazur,
G.Jeans,
B.L.Barnett,
R.G.G.Russell.
New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption To Be Published.
Page generated: Thu Aug 1 05:23:13 2024
|
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |